These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 16750627)

  • 21. Inhibition of cancer cell adhesion by heterochiral Pro-containing RGD mimetics.
    Gentilucci L; Cardillo G; Squassabia F; Tolomelli A; Spampinato S; Sparta A; Baiula M
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2329-33. PubMed ID: 17289386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of peptidomimetics that inhibit the association of phosphatidylinositol 3-kinase with platelet-derived growth factor-beta receptor and possess cellular activity.
    Eaton SR; Cody WL; Doherty AM; Holland DR; Panek RL; Lu GH; Dahring TK; Rose DR
    J Med Chem; 1998 Oct; 41(22):4329-42. PubMed ID: 9784108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel RGD-like molecules based on the tyrosine template: design, synthesis, and biological evaluation on isolated integrins alphaVbeta3/alphaIIbbeta3 and in cellular adhesion tests.
    Biltresse S; Attolini M; Dive G; Cordi A; Tucker GC; Marchand-Brynaert J
    Bioorg Med Chem; 2004 Oct; 12(20):5379-93. PubMed ID: 15388165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of RGD analogs as potential vectors for targeted drug delivery.
    Jiang J; Wang W; Sane DC; Wang B
    Bioorg Chem; 2001 Dec; 29(6):357-79. PubMed ID: 11846434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrroloisoquinoline-based tetrapeptide analogues mimicking reverse-turn secondary structures.
    Landoni N; Lesma G; Sacchetti A; Silvani A
    J Org Chem; 2007 Dec; 72(25):9765-8. PubMed ID: 17990894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spatial conformation and topography of the tyrosine aromatic ring in substrate recognition by protein tyrosine kinases.
    Ruzza P; Cesaro L; Tourwé D; Calderan A; Biondi B; Maes V; Menegazzo I; Osler A; Rubini C; Guiotto A; Pinna LA; Borin G; Donella-Deana A
    J Med Chem; 2006 Mar; 49(6):1916-24. PubMed ID: 16539378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and in vitro activity of peptidomimetic inhibitors of myeloid differentiation factor 88.
    Fantò N; Gallo G; Ciacci A; Semproni M; Vignola D; Quaglia M; Bombardi V; Mastroianni D; Zibella MP; Basile G; Sassano M; Ruggiero V; De Santis R; Carminati P
    J Med Chem; 2008 Mar; 51(5):1189-202. PubMed ID: 18275134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor.
    Georgsson J; Sköld C; Botros M; Lindeberg G; Nyberg F; Karlén A; Hallberg A; Larhed M
    J Med Chem; 2007 Apr; 50(7):1711-5. PubMed ID: 17358051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell adhesive PET membranes by surface grafting of RGD peptidomimetics.
    Biltresse S; Attolini M; Marchand-Brynaert J
    Biomaterials; 2005 Aug; 26(22):4576-87. PubMed ID: 15722127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of a novel cis-proline-derived cyclic type VI beta-turn mimic via ring-closing metathesis.
    Boruah A; Rao IN; Nandy JP; Kumar SK; Kunwar AC; Iqbal J
    J Org Chem; 2003 Jun; 68(12):5006-8. PubMed ID: 12790624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of lactam-bridged neurotensin analogues adjusting psi(Pro10) close to the experimentally derived bioactive conformation of NT(8-13).
    Bittermann H; Einsiedel J; Hübner H; Gmeiner P
    J Med Chem; 2004 Oct; 47(22):5587-90. PubMed ID: 15481995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trishomocubane amino acid as a beta-turn scaffold.
    Albericio F; Arvidson PI; Bisetty K; Giralt E; Govender T; Jali S; Kongsaeree P; Kruger HG; Prabpai S
    Chem Biol Drug Des; 2008 Feb; 71(2):125-30. PubMed ID: 18205726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A bioconjugate of Lys and Arg mimics biological activity of the Arg-Gly-Asp peptide sequence.
    Ehteshami G; Brune DC; Lopez JC; Massia SP
    Acta Biomater; 2005 Jan; 1(1):85-91. PubMed ID: 16701782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facile synthesis of @-tide beta-strand peptidomimetics: improved assembly in solution and on solid phase.
    Phillips ST; Piersanti G; Rüth M; Gubernator N; van Lengerich B; Bartlett PA
    Org Lett; 2004 Nov; 6(24):4483-5. PubMed ID: 15548056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereocontrolled synthesis of psi[CH(CF3)NH]gly-peptides.
    Molteni M; Volonterio A; Zanda M
    Org Lett; 2003 Oct; 5(21):3887-90. PubMed ID: 14535735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine modified analogues of the α4β7 integrin inhibitor biotin-R₈ERY prepared via Click Chemistry: synthesis and biological evaluation.
    Papst S; Noisier A; Brimble MA; Yang Y; Krissansen GW
    Bioorg Med Chem; 2012 Apr; 20(8):2638-44. PubMed ID: 22421276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parallel synthesis and biological evaluation of different sizes of bicyclo[2,3]-Leu-enkephalin analogues.
    Gu X; Ying J; Min B; Cain JP; Davis P; Willey P; Navratilova E; Yamamura HI; Porreca F; Hruby VJ
    Biopolymers; 2005; 80(2-3):151-63. PubMed ID: 15660379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic RGD-containing alpha-helical coiled coil peptides promote integrin-dependent cell adhesion.
    Villard V; Kalyuzhniy O; Riccio O; Potekhin S; Melnik TN; Kajava AV; Rüegg C; Corradin G
    J Pept Sci; 2006 Mar; 12(3):206-12. PubMed ID: 16103993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding.
    Nam NH; Ye G; Sun G; Parang K
    J Med Chem; 2004 Jun; 47(12):3131-41. PubMed ID: 15163193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of potent cyclic hexapeptide NK-1 antagonists. Use of a minilibrary in transforming a peptidal somatostatin receptor ligand into an NK-1 receptor ligand via a polyvalent peptidomimetic.
    Hirschmann R; Yao W; Cascieri MA; Strader CD; Maechler L; Cichy-Knight MA; Hynes J; van Rijn RD; Sprengeler PA; Smith AB
    J Med Chem; 1996 Jun; 39(13):2441-8. PubMed ID: 8691440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.